Dr. Arindam Pramanik
- Position: Postdoctoral research fellow
- Areas of expertise: Cell Biology; Cancer Therapeutics; Cancer Biomarkers; Targeted Drug Delivery; Gene Therapy; Animal Model Studies
- Email: A.Pramanik@leeds.ac.uk
- Location: Wellcome Trust Brenner Building, St James University Hospital, Leeds
- Website: LinkedIn | Googlescholar | Researchgate | ORCID
Dr. Arindam Pramanik is a postdoctoral research fellow in School of Medicine since 2019 and working on natural anticancer peptides and its therapeutic application on Breast Cancer. His research focuses on increasing the specificity and the potency of these peptides to triple negative breast cancer cells.
Before joining School of Medicine, Arindam was working as a Newton postdoctoral fellow (funded by Academy of Medical Science) in the Faculty of Biological Science at University of Leeds during 2017-2018. His research was focused on targeted therapeutics delivery in cancer cells. During this period he developed a strategy of using Affimer protein molecules as a ligand against carcinoembryonic antigens on colon and breast cancers. These Affimers were conjugated on the surface of the lipid nanocarriers called 'cubosome' to deliver them specifically to the tumor site in-vivo. He presented his work in Oregon State University, USA in their 16th International Nanomedicine & Drug Delivery symposium at Portland where he received the “Joe Gray Travel award” in September 2018.
Arindam completed his PhD from India (Jadavpur University) and his doctoral research was on targeted drug delivery to cancer cells using polymeric and metal based nanoparticle. Post PhD, he was awarded by two National level Post-Doctoral Fellowships by DST (Department of Science and Technology, Government of India) and DBT (Department of Biotechnology, Government of India). Before joining University of Leeds, he was working in the School of Biological Science at Indian Association for Cultivation of Science, Kolkata Indian on the DST funded National postdoctoral fellow in 2016.
- Natural peptides as cancer therapeutics
- Liposomal Nanostructures (Cubosomes), Polymeric (Chitosan) nanoparticle
- Cancer Biomarkers
- Assessment and application of tagged delivery vehicles in in-vivo systems
- Hydrogel as cancer therapeutics
- Biopolymers – Structures and Drug Delivery Potential
- PhD - Life Science and Biotechnology
- Masters of Science - Microbiology
- Bachelors of Science - Microbiology, Chemistry, Zoology
- Guest Editor for Frontiers of Chemistry issue: Immunomodulatory Nanomaterials in Cancer Theranostics
- Guest editor for Journal of Applied Sciences